Eli Lilly have at least one repurposed drug in Phase 3 trial to treat COVID : https://investor.lilly.com/news-releases/news-release-details/lilly-begins-phase-3-clinical-trial-baricitinib-hospitalized
Baricitinib is owned by Incyte, which popped about $4B USD in MC on the news its product was being trialled. I would expect a similar pop for PAA if MPL gets to Phase 3, say $6B AUD. So my rough calculation is PAA gets to $20 a share BEFORE MPLs effectiveness is proven (or not).
THEN, I’ll know the pressure the holders of 2 million shares are feeling this weekend.
- Forums
- ASX - By Stock
- PAA
- Clinical Trials
Clinical Trials, page-301
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $94.79M |
Open | High | Low | Value | Volume |
20.5¢ | 20.5¢ | 19.5¢ | $188.9K | 946.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 800531 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 49199 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 75256 | 0.195 |
11 | 700531 | 0.190 |
14 | 251884 | 0.185 |
21 | 365493 | 0.180 |
4 | 261730 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 1 | 1 |
0.195 | 142199 | 2 |
0.200 | 91888 | 5 |
0.205 | 15000 | 1 |
0.210 | 178232 | 4 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |